Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 8
Submit an article Journal homepage
46
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Noncompaction and the novel variant c.425A>T in TPM1

Josef Finsterera Messerli Institute, Klinik Landstrasse, Postfach 20, 1180Vienna, AustriaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2839-7305
ORCID Icon,
Claudia Stöllbergerb 2nd Medical Department with Cardiology and Intensive Care Medicine, Klinik Landstrasse, Vienna, Austria
&
Franco Lacconec Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria
Pages 758-759 | Received 22 Feb 2021, Accepted 07 Jul 2021, Published online: 26 Jul 2021
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days
"Noncompaction and the novel variant c.425A>T in TPM1." Acta Cardiologica, 77(8), pp. 758–759

Ethical approval

The study was approved by the institutional review board. Informed consent was obtained.

Author contributions

JF: design, literature search, discussion, first draft, critical comments, CS: data acquisition, discussion, final approval, FL: data acquisition, discussion, final approval.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.